The Fall 2026 issue of THE SOURCE, the magazine of the Plasma Protein Therapeutics Association (PPTA), explores the people, partnerships, policies, and initiatives shaping the global plasma community. With a focus on plasma awareness, patient access, advocacy, regulatory collaboration, and the people behind plasma donation, this issue highlights:
- Regulatory collaboration and innovation, including an in-depth look at the European Medicines Agency’s Product Management Service (PMS) and how industry expertise is helping shape a more harmonized and efficient regulatory environment.
- The evolving healthcare policy landscape, including how the 2026 U.S. midterm elections and potential changes in Congress could affect drug pricing, reimbursement, supply chains, and access to plasma-derived therapies.
- Advocacy and engagement, spotlighting PPTA’s Congressional Fly-In and efforts to bring the voices of patients, donors, manufacturers, and advocates to Capitol Hill.
- Global supply resiliency, including the Plasma Project in Brazil and efforts to build greater awareness of plasma’s essential role in immunoglobulin production and strengthen long-term supply security.